Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues

Tongtong Zou, A. Steven Fleisher, Dehe Kong, Jing Yin, Rhonda F. Souza, Suna Wang, Kara N. Smolinski, John M. Abraham, Stephen Meltzer

Research output: Contribution to journalArticle

Abstract

Insulin-like growth factor binding protein 3 (IGFBP-3) is an important regulator of normal and malignant cell growth. It modulates the mitogenic effects of insulin-like growth factors (IGFs) by inhibiting growth through mechanisms both dependent on and independent of IGF binding. IGF-I and IGF- II levels are regulated by binding to the IGF-II receptor, which is inactivated by mutation in human gastrointestinal (GI) tumors. We have previously demonstrated elevated IGF-II ligand expression in IGF-II receptor- mutant GI tumors, implicating the IGF signaling system in GI tumorigenesis. Therefore, to investigate the potential involvement of IGFBP-3 in human GI carcinogenesis, direct DNA sequencing of exons 1-4 and intron-exon boundaries of the IGFBP-3 gene was performed in 10 colorectal cancers, 10 gastric cancers, and 10 esophageal cancers. Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC→CCC), leading to a His→Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC→ATC), leading to a Thr→Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG→GCG), leading to a Gly→Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers. All of these DNA sequence alterations were present in matched normal DNA from the same subjects, which suggests that some or all of them may represent polymorphisms. However, we cannot exclude the possibility that the germ-line nonconservative amino acid substitutions predicted to occur as a result of these alterations result in subtle changes to IGFBP-3 protein function and a predisposition to developing GI malignancy.

Original languageEnglish (US)
Pages (from-to)4802-4804
Number of pages3
JournalCancer Research
Volume58
Issue number21
StatePublished - Nov 1 1998
Externally publishedYes

Fingerprint

Insulin-Like Growth Factor Binding Protein 3
Somatomedins
Esophageal Neoplasms
Nucleotides
Codon
Colonic Neoplasms
IGF Type 2 Receptor
Stomach Neoplasms
Exons
Insulin-Like Growth Factor II
Neoplasms
Introns
Carcinogenesis
Dilatation and Curettage
RNA Splice Sites
Amino Acid Substitution
Growth
Insulin-Like Growth Factor I
DNA Sequence Analysis
Germ Cells

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues. / Zou, Tongtong; Fleisher, A. Steven; Kong, Dehe; Yin, Jing; Souza, Rhonda F.; Wang, Suna; Smolinski, Kara N.; Abraham, John M.; Meltzer, Stephen.

In: Cancer Research, Vol. 58, No. 21, 01.11.1998, p. 4802-4804.

Research output: Contribution to journalArticle

Zou, T, Fleisher, AS, Kong, D, Yin, J, Souza, RF, Wang, S, Smolinski, KN, Abraham, JM & Meltzer, S 1998, 'Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues', Cancer Research, vol. 58, no. 21, pp. 4802-4804.
Zou, Tongtong ; Fleisher, A. Steven ; Kong, Dehe ; Yin, Jing ; Souza, Rhonda F. ; Wang, Suna ; Smolinski, Kara N. ; Abraham, John M. ; Meltzer, Stephen. / Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues. In: Cancer Research. 1998 ; Vol. 58, No. 21. pp. 4802-4804.
@article{5fa25d307e6c4af9ad1ec3ba29010c79,
title = "Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues",
abstract = "Insulin-like growth factor binding protein 3 (IGFBP-3) is an important regulator of normal and malignant cell growth. It modulates the mitogenic effects of insulin-like growth factors (IGFs) by inhibiting growth through mechanisms both dependent on and independent of IGF binding. IGF-I and IGF- II levels are regulated by binding to the IGF-II receptor, which is inactivated by mutation in human gastrointestinal (GI) tumors. We have previously demonstrated elevated IGF-II ligand expression in IGF-II receptor- mutant GI tumors, implicating the IGF signaling system in GI tumorigenesis. Therefore, to investigate the potential involvement of IGFBP-3 in human GI carcinogenesis, direct DNA sequencing of exons 1-4 and intron-exon boundaries of the IGFBP-3 gene was performed in 10 colorectal cancers, 10 gastric cancers, and 10 esophageal cancers. Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC→CCC), leading to a His→Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC→ATC), leading to a Thr→Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG→GCG), leading to a Gly→Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers. All of these DNA sequence alterations were present in matched normal DNA from the same subjects, which suggests that some or all of them may represent polymorphisms. However, we cannot exclude the possibility that the germ-line nonconservative amino acid substitutions predicted to occur as a result of these alterations result in subtle changes to IGFBP-3 protein function and a predisposition to developing GI malignancy.",
author = "Tongtong Zou and Fleisher, {A. Steven} and Dehe Kong and Jing Yin and Souza, {Rhonda F.} and Suna Wang and Smolinski, {Kara N.} and Abraham, {John M.} and Stephen Meltzer",
year = "1998",
month = "11",
day = "1",
language = "English (US)",
volume = "58",
pages = "4802--4804",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "21",

}

TY - JOUR

T1 - Sequence alterations of insulin-like growth factor binding protein 3 in neoplastic and normal gastrointestinal tissues

AU - Zou, Tongtong

AU - Fleisher, A. Steven

AU - Kong, Dehe

AU - Yin, Jing

AU - Souza, Rhonda F.

AU - Wang, Suna

AU - Smolinski, Kara N.

AU - Abraham, John M.

AU - Meltzer, Stephen

PY - 1998/11/1

Y1 - 1998/11/1

N2 - Insulin-like growth factor binding protein 3 (IGFBP-3) is an important regulator of normal and malignant cell growth. It modulates the mitogenic effects of insulin-like growth factors (IGFs) by inhibiting growth through mechanisms both dependent on and independent of IGF binding. IGF-I and IGF- II levels are regulated by binding to the IGF-II receptor, which is inactivated by mutation in human gastrointestinal (GI) tumors. We have previously demonstrated elevated IGF-II ligand expression in IGF-II receptor- mutant GI tumors, implicating the IGF signaling system in GI tumorigenesis. Therefore, to investigate the potential involvement of IGFBP-3 in human GI carcinogenesis, direct DNA sequencing of exons 1-4 and intron-exon boundaries of the IGFBP-3 gene was performed in 10 colorectal cancers, 10 gastric cancers, and 10 esophageal cancers. Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC→CCC), leading to a His→Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC→ATC), leading to a Thr→Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG→GCG), leading to a Gly→Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers. All of these DNA sequence alterations were present in matched normal DNA from the same subjects, which suggests that some or all of them may represent polymorphisms. However, we cannot exclude the possibility that the germ-line nonconservative amino acid substitutions predicted to occur as a result of these alterations result in subtle changes to IGFBP-3 protein function and a predisposition to developing GI malignancy.

AB - Insulin-like growth factor binding protein 3 (IGFBP-3) is an important regulator of normal and malignant cell growth. It modulates the mitogenic effects of insulin-like growth factors (IGFs) by inhibiting growth through mechanisms both dependent on and independent of IGF binding. IGF-I and IGF- II levels are regulated by binding to the IGF-II receptor, which is inactivated by mutation in human gastrointestinal (GI) tumors. We have previously demonstrated elevated IGF-II ligand expression in IGF-II receptor- mutant GI tumors, implicating the IGF signaling system in GI tumorigenesis. Therefore, to investigate the potential involvement of IGFBP-3 in human GI carcinogenesis, direct DNA sequencing of exons 1-4 and intron-exon boundaries of the IGFBP-3 gene was performed in 10 colorectal cancers, 10 gastric cancers, and 10 esophageal cancers. Four distinct sequence alterations were identified: (a) in one gastric and one esophageal tumor, an A to C transversion occurred at nucleotide 5795 (CAC→CCC), leading to a His→Pro substitution at codon 179; (b) a second esophageal tumor had a C to T transition at nucleotide 8291 (ACC→ATC), leading to a Thr→Ile substitution at codon 277 of IGFBP-3; (c) one alteration comprised a G to C transversion in exon 1 at nucleotide 2132 (GGG→GCG), leading to a Gly→Ala substitution at codon 32 in two gastric cancers, seven esophageal cancers, and nine colon cancers; and (d) a C to G transversion located 17 nucleotides from the 3' splice site in intron 1 was observed in three colon cancers and four esophageal cancers. All of these DNA sequence alterations were present in matched normal DNA from the same subjects, which suggests that some or all of them may represent polymorphisms. However, we cannot exclude the possibility that the germ-line nonconservative amino acid substitutions predicted to occur as a result of these alterations result in subtle changes to IGFBP-3 protein function and a predisposition to developing GI malignancy.

UR - http://www.scopus.com/inward/record.url?scp=0032213487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032213487&partnerID=8YFLogxK

M3 - Article

VL - 58

SP - 4802

EP - 4804

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 21

ER -